X
28Jun

[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action

Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By: Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/

Related

Environmental Considerations in Corporate Transactions

My partner Bob Melvin and I recently gave a presentation on environmental, health, and safety consid...

Read More >

Beware of the Risks! No Ownership, No Lien

A recent North Carolina Court of Appeals decision reiterates the importance of knowing who you are d...

Read More >

Protecting Deal Value: A Cybersecurity Point of View - Managing Cybersecurity-Related Merger and Acquisition Risks

Once typically excluded from the mergers and acquisitions (“M&A”) due diligence checklist, cyberse...

Read More >

SSA No-Match Letters – What You Need to Know

The Social Security Administration (SSA) resumed sending Employer Correction Request Notices, more c...

Read More >

What a Business Should Know Before Triggering a MAC Clause Based on COVID-19

The COVID-19 pandemic has caused a sudden disruption to businesses and halted almost all forms of gl...

Read More >

Legal issues for UK construction businesses (UPDATED)

Our latest articles on recent issues and news affecting UK construction businesses. Brexit – and...

Read More >